Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD + THC versus placebo for motor and non-motor symptoms in Parkinson's disease
RBR-10n7gx74Phase 3Completed
- Sponsor
- Federal University of Latin American Integration
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cannabidiol and dronabinol in Parkinson's disease (PD) (2 arms), sponsored by Federal University of Latin American Integration. Started Jan 2024; status: completed.
02
Drugs
cannabidioldronabinol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on RBR-10n7gx74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10n7gx74.